Skip to main content

Day: August 28, 2024

HOOKIPA Pharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

NEW YORK and VIENNA, Aug. 28, 2024 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (NASDAQ: HOOK, “HOOKIPA”, the “Company”), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that members of the management team will participate in the H.C. Wainwright 26th Annual Global Investment Conference, taking place from September 9th-11th, 2024 in New York. Dr. Malte Peters, Hookipa’s Chief Executive Officer, and Terry Coelho, Executive Vice President & Chief Financial Officer will be hosting one-on-one meetings with investors during the conference. In addition, Dr. Peters will participate in a Fireside Chat on Monday, September 9, 2024 at 1:30 p.m. ET. The fireside chat will be available via webcast through the following link: https://journey.ct.events/view/a5640121-61ef-4c2b-8017-b6b346ca2547 A...

Continue reading

SciSparc Grants Global Rights for Pain Therapy to Biotech Company in Agreement Worth up to $6 Million

SciSparc would be entitled to receive consideration valued at $3 million in Polyrizon securities, as well as potential milestone fees of approximately $3 million in cash TEL AVIV, Israel, Aug. 28, 2024 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced that it has finalized an Exclusive Patent License Agreement (“the License Agreement”) with Polyrizon Ltd. (“Polyrizon”), for the out-licensing of its SCI-160 program (the “Assets”) for the treatment of pain. As announced on August 15, 2024, Polyrizon will receive exclusive, royalty-bearing global license to develop and sublicense the Assets. In exchange, SciSparc would...

Continue reading

ECD Auto Design’s Newest Beach Runner Rolls Off the Line, Ready for the Coast

KISSIMMEE, Fla., Aug. 28, 2024 (GLOBE NEWSWIRE) — ECD Automotive Design, renowned for its bespoke custom luxury vehicles, is thrilled to announce the launch of its latest masterpiece: The Beach Runner 3. The third vehicle in the Beach Runner series is meticulously crafted to combine the ruggedness of a classic Land Rover with the innovative customization of a coastal and beach focused vehicle. View high-resolution images and video HERE. Built for coastal and beach living and finished in a stunning Cornish Cream gloss paint, the Beach Runner 3 is sure to turn heads just as its first two predecessors. The vehicle features a cohesive body color scheme, including wheel spats, grille, light surrounds, hinges, Optimill air intakes, and a custom roll cage. The power retractable side steps, rear light guards and work light are painted...

Continue reading

NurExone Reports Second Quarter 2024 Financial Results and Provides Corporate Update

TORONTO and HAIFA, Israel, Aug. 28, 2024 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company developing regenerative medicine therapies, is pleased to announce its financial and operational results for the three and six months ended June 30, 2024, the highlights of which are included in this news release. The Company’s complete set of condensed interim consolidated financial statements for the three and six months ended June 30, 2024, and accompanying management’s discussion and analysis for the period can be accessed by visiting the Company’s website at www.nurexone.com and its profile page on SEDAR+ at www.sedarplus.ca. Key Business Highlights On April 1, 2024, the Company entered into a contract research organization services...

Continue reading

Award-Winning Media and Creator company Underknown Acquires “Animalogic” from Blue Ant Media

Underknown Buys Animalogic from Blue Ant MediaWebby-award-winning digital-first media company Underknown announces today it has purchased the popular YouTube channel “Animalogic” from international production studio, rights business and channel operator, Blue Ant Media.The acquisition sees “Animalogic” join the Underknown suite of video channels which includes the popular shows: What If, Aperture, and How to Survive. This deal marks the second acquisition in three years for Underknown as they expand their portfolio of brands.TORONTO, Aug. 28, 2024 (GLOBE NEWSWIRE) — Webby-award-winning digital-first media company Underknown announces today it has purchased the popular YouTube channel “Animalogic” from international production studio, rights business and channel operator, Blue Ant Media. The acquisition sees “Animalogic”...

Continue reading

AgriFORCE Completes Acquisition of Radical Clean Solutions

Strategic acquisition strengthens IP portfolio with the addition of patent-pending technology proven to eliminate pathogens in food production and storage facilities and indoor farms, commercial and industrial applications, hospitals, schools, residential applications and more VANCOUVER, British Columbia, Aug. 28, 2024 (GLOBE NEWSWIRE) — AgriFORCE Growing Systems Ltd. (the “Company”) (NASDAQ: AGRI; AGRIW), an intellectual property (“IP”) focused technology company, announces the closing of the acquisition of the assets of Radical Clean Solutions Limited (“RCS”) for which the Company has held worldwide rights in the agriculture space. The RCS Hydroxyl Technology generates and distributes hydroxyl radicals, highly reactive molecules that target and break down pathogens, virus, mold, volatile organic compounds, and other contaminants...

Continue reading

Westrock Coffee Company Commences Warrant Exchange Offer and Consent Solicitation

LITTLE ROCK, Ark., Aug. 28, 2024 (GLOBE NEWSWIRE) — Westrock Coffee Company (NASDAQ: WEST) (“Westrock Coffee” or the “Company”), a leading integrated coffee, tea, flavors, extracts, and ingredients solutions provider in the United States, today announced that it has commenced an exchange offer (the “Offer”) and consent solicitation (the “Consent Solicitation”) relating to its outstanding (i) public warrants to purchase shares of common stock of the Company, par value $0.01 per share (“common shares”), which warrants trade on The Nasdaq Global Market under the symbol “WESTW” (the “public warrants”), and (ii) private placement warrants to purchase common shares (the “private placement warrants” and, together with the public warrants, the “warrants”). The purpose of the Offer and Consent Solicitation is to simplify the Company’s capital...

Continue reading

Data Center Colocation Market to Reach USD 195.09 Billion by 2031 | SkyQuest Technology

Westford, USA, Aug. 28, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the Global Data Center Colocation Market will reach a value of USD 195.09 Billion by 2031, with a CAGR of 15.3% during the forecast period (2024-2031). The growing demand for IT infrastructure required by businesses has surged over the past few years. Today, companies are highly dependent on data, leading to increased implementation of cloud services. Colocation data centers have allowed fast scaling of IT needs of companies. In addition, growing prices of keeping and maintenance of data centers for businesses to produce varying data quantities are significantly impacting the market growth. Download a detailed overview: https://www.skyquestt.com/sample-request/data-center-colocation-market Browse in-depth TOC on the “Data Center Colocation Market”Pages...

Continue reading

Abercrombie & Fitch Co. Reports Second Quarter Fiscal 2024 Results

Record second quarter net sales of $1.1 billion, up 21% from last year with comparable sales growth of 18% Broad-based net sales growth across regions and brands, with Abercrombie brands growth of 26% and Hollister brands accelerating to growth of 17% Operating margin expands 590 basis points to 15.5%, with record second quarter operating income of $176 million Further strengthened balance sheet with redemption of all its outstanding 8.75% senior secured notes and amendment and extension of ABL Facility resulting in liquidity of $1.2 billion Increases full year outlook to net sales growth of 12% to 13%, and operating margin in the range of 14% to 15%NEW ALBANY, Ohio, Aug. 28, 2024 (GLOBE NEWSWIRE) — Abercrombie & Fitch Co. (NYSE: ANF) today announced results for the second quarter ended August 3, 2024. These compare to...

Continue reading

Intra-Cellular Therapies to Present at Three Upcoming Investor Conferences

NEW YORK, Aug. 28, 2024 (GLOBE NEWSWIRE) — Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at three upcoming investor conferences: Morgan Stanley 22nd Annual Global Healthcare ConferenceWednesday, September 4, 2024 at 10:00 a.m. ET in New York, NY Baird’s 2024 Global Healthcare ConferenceWednesday, September 11, 2024 at 11:25 a.m. ET in New York, NY 2024 Cantor Global Healthcare ConferenceWednesday, September 18, 2024 at 10:55 a.m. ET in New York, NY A live and achieved webcast of the presentations can be accessed under “Events & Presentations” in the Investors section of the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.